Gabapentin for muscle spasticity
Pro Research Analysisby 
Searched over 200M research papers
Gabapentin for Muscle Spasticity: Efficacy and Safety
Clinical Effectiveness of Gabapentin for Spasticity
Gabapentin has been studied as a treatment for muscle spasticity in various neurological conditions, including upper motor neuron syndrome, multiple sclerosis (MS), and spinal cord injury (SCI). Multiple randomized, placebo-controlled trials have shown that gabapentin can significantly reduce spasticity, as measured by the Ashworth Scale and other clinical assessments, in patients with upper motor neuron lesions and MS 123. Improvements were also noted in patient-reported outcomes, such as reductions in painful muscle spasms and interference with daily function 23. Case reports and small studies in MS patients further support gabapentin’s ability to decrease spasticity and improve functional outcomes without significant side effects .
Gabapentin in Spinal Cord Injury-Related Spasticity
In patients with SCI, gabapentin has demonstrated modest but significant reductions in spasticity, as measured by clinical scales and patient ratings 57. Some studies found that higher doses of gabapentin (up to 3,600 mg/day) provided greater control of spasticity, with improvements sometimes detected by quantitative EMG assessments even when not clinically obvious . Animal studies also show that gabapentin can attenuate both muscular spasticity and autonomic dysreflexia in response to noxious stimuli after SCI 48.
Comparative Effectiveness and Role Among Antispasticity Drugs
Meta-analyses and reviews indicate that gabapentin, along with other oral antispasticity drugs like baclofen, tizanidine, diazepam, and dantrolene, is moderately effective in managing spasticity in non-progressive neurological diseases 910. While traditional agents such as baclofen and tizanidine remain first-line treatments, gabapentin is recognized as a valuable alternative, especially for patients who are refractory to or intolerant of other medications .
Safety and Tolerability of Gabapentin
Gabapentin is generally well tolerated, with fewer adverse events and withdrawals compared to placebo in clinical trials . Importantly, studies have not found significant negative effects on concentration, fatigue, or gait during gabapentin treatment 13. This favorable safety profile makes gabapentin a suitable option for long-term management of spasticity in various neurological conditions.
Conclusion
Gabapentin is an effective and safe option for reducing muscle spasticity in patients with upper motor neuron syndrome, multiple sclerosis, and spinal cord injury. It offers moderate benefits, particularly at higher doses, and is well tolerated with minimal side effects. Gabapentin is a useful alternative or adjunct to traditional antispasticity medications, especially for patients who do not respond to or cannot tolerate other therapies 123567910.
Sources and full results
Most relevant research papers on this topic